Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Halozyme Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get HALO alerts

About Mark Snyder

Mark Snyder is recorded as General Counsel at Halozyme Therapeutics, Inc. (HALO). The newest filing on record that lists Mark Snyder as General Counsel at Halozyme Therapeutics, Inc. (HALO) is dated March 24, 2023. The proxy statement of Halozyme Therapeutics, Inc. reports total compensation of $4,531,568 for Mark Snyder in fiscal 2025, including a base salary of $619,000. Disclosed compensation is on record for 4 fiscal years. Halozyme Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Halozyme Therapeutics, Inc. includes Helen Torley (CEO and Board Member), Darren Snellgrove (CFO), Elaine D. Sun (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Halozyme Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Halozyme Therapeutics, Inc. (HALO) $619,000 $4,531,568
2024 Halozyme Therapeutics, Inc. (HALO) $579,000 $5,394,865
2023 Halozyme Therapeutics, Inc. (HALO) $546,000 $3,612,927
2022 Halozyme Therapeutics, Inc. (HALO) $525,000 $3,740,202

Recent activity

No call appearances or filed executive changes recorded yet.